Outcome of living unrelated (commercial) renal transplantation: report of 20 cases.
Ben Hamida
F
F
Department of Nephrology and Internal Medicine, Charles Nicolle Hospital, Tunis, Tunisia.
Ben Abdallah
T
T
Goucha
R
R
Hedri
H
H
Helal
I
I
Karoui
C
C
Abderrahim
E
E
Ben Moussa
F
F
Kheder
A
A
Ben Maïz
H
H
D000293:Adolescent; D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D002102:Cadaver; D002648:Child; D004359:Drug Therapy, Combination; D004992:Ethics, Medical; D005190:Family; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology / Q000209:etiology; D006085:Graft Survival / Q000502:physiology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007182:Income; D007676:Kidney Failure, Chronic / Q000601:surgery*; D016030:Kidney Transplantation / Q000401:mortality / Q000502:physiology*; D019520:Living Donors; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D011183:Postoperative Complications / Q000145:classification / Q000453:epidemiology; D012008:Recurrence; D012189:Retrospective Studies; D013997:Time Factors; D014019:Tissue Donors; D016896:Treatment Outcome; D014416:Tunisia
D000961:Antilymphocyte Serum; D008775:Methylprednisolone